Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocartis
Mechelen, Belgiumbiocartis.com ↗
- Ownership
- Public · BCART
- Employees
- ~450
- Development stage
- Other
01
Overview
Biocartis has commercialized the Idylla™ platform with a growing menu of oncology and infectious disease tests. The company’s products enable fast, in-house molecular testing without specialized lab infrastructure. Clinical results have demonstrated rapid turnaround times and high accuracy for actionable biomarker detection in various cancers and infectious diseases. The company continues to expand its test menu through internal R&D and external collaborations.
- Therapeutic areas
- Infectious DiseasesHematologyOncology
- Modalities
- PCR-based molecular diagnostics (real-time PCR)Genomic assays for mutation detection and infectious disease testing
- Industry
- Molecular Diagnostics
02
Partnerships
Amgen – evaluation of RAS testing for decentralized access using the Idylla platformBristol Myers Squibb – registration/use of MSI test in immuno-oncology therapiesGeneproDx – co-development of ThyroidPrint on the platformAPIS Assay Technologies Ltd. – breast cancer subtyping test development
03
Financials
- Market cap
- $18.8M
- Total revenue
- $11M
- Enterprise value
- $-19.6M
Beyond the preview
Go deeper on Biocartis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biocartis.